The OMICS Group is planning to organise 3rd International conference and exhibition on pharmacovigilance and clinical trials from October 27-29th in Hyderabad.

The main objective of the conference is to focus on latest developments in pharmacovigilance, drug safety and risk management. The conference is also expected to create awareness among all the stake holders of the pharma, hospitals, doctors and patients about the importance of pharmacovigilance and clinical trials in bringing safer and newer drugs for the well being of the society.

According to Dr M. Venkata Reddy, director, Hitech Institute of Advance Pharmaceutical Sciences, pharmacovigilance in India is neglected. The government should take proactive steps to set up more pharmacovigilance centres across the country so that more adverse drug reaction (ADR) cases can be recorded and based on that the pharma companies will make more efforts to bring in more safer drugs to the society.

Dr. Reddy pointed that when USA and EU are doing lakhs of clinical trials and recording thousands of ADRs, in India yearly only 2000 clinical trials are being conducted and almost negligible amount of ADRs are reported. “Because there is no proper active mechanise to report ADR in India, there are large number of cases of adverse drug reactions going unnoticed. To improve the drug safety and to develop new drugs for various diseases, pharmacovigilance and clinical trials are very important.”

In fact pharmacovigilance is the pharmacological science relating to the collection, detection, assessment, monitoring and prevention of adverse effects with pharmaceutical products. To propagate more about this subject, the international conference at Hyderabad International convention centre is coming with a theme ‘safer drugs to market by analysing latest development in pharmacovigilance, drug safety and risk management’.

As more and more drugs are flooding the markets, it is important to assess the effect and impact of the drugs on humans from time to time. Moreover with the widespread use of herbals, traditional and complementary medicines, blood products, biologicals, medical devices and vaccines, the concerns are even more higher and the role of pharmacovigilance to ensure safer drugs to the society is significant, opined Dr. Srinubabu Gadela, managing director of OMICS Group.

“As medical intake among people is increasing dramatically, governments need to set up more pharmacovigilance centres and strengthen regulatory practices and procedures to assure the safety of medicines before and after they reach the market,” said, S.V. Krishna Prasad, chief executive officer, of Cito Healthcare, while talking about the importance of pharmacovigilance.